ロード中...
Aflibercept: a Potent Vascular Endothelial Growth Factor Antagonist for Neovascular Age-Related Macular Degeneration and Other Retinal Vascular Diseases
INTRODUCTION: In the western hemisphere, age-related macular degeneration (AMD) is the leading cause of visual loss in the elderly. Currently approved therapies for AMD include argon laser, photodynamic therapy, and antivascular endothelial growth factor (VEGF) therapy. The index review discusses af...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare Communications
2012
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3873045/ https://ncbi.nlm.nih.gov/pubmed/24392297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13554-012-0003-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|